Child Development — Children Participation Assessment Scale
Citation(s)
Amini M, Hassani Mehraban A, Pashmdarfard M, Cheraghifard M Reliability and validity of the Children Participation Assessment Scale in Activities Outside of School-Parent version for children with physical disabilities. Aust Occup Ther J. 2019 Aug;66(4):482-489. doi: 10.1111/1440-1630.12569. Epub 2019 Jan 30.
Amini M, Hassani Mehraban A, Rostamzadeh O, Mehdizadeh F Psychometric Properties of the Iranian-Children Participation Questionnaire (I-CPQ) When Used with Parents of Preschool Children with Cerebral Palsy. Occup Ther Health Care. 2017 Oct;31(4):341-351. doi: 10.1080/07380577.2017.1382753. Epub 2017 Oct 17.
Parsons SK, Shih MC, Mayer DK, Barlow SE, Supran SE, Levy SL, Greenfield S, Kaplan SH Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children. Qual Life Res. 2005 Aug;14(6):1613-25. doi: 10.1007/s11136-005-1004-2.
Turkish Version, Validity and Reliability Study of the "Children Participation Assessment Scale"
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
